Acrobiosystems for English
icon_bulk_orderAchat groupé/Commande rapide
user
  1. Tableau de bord
  2. Mon profil
  3. Mon adresse
  4. Mes commandes
  5. Adhésion à Acro
Connexion Inscription
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
Il n'y a pas de produit dans le panier !
Mon panier|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Fc gamma RIIB/C / CD32b/c

Fc gamma RIIB/C / CD32b/c

Brief Information

Name:Low affinity immunoglobulin gamma Fc region receptor II-b
Target Synonym:IgG Fc Receptor II-C,Fc Fragment Of IgG, Low Affinity IIb, Receptor (CD32),Fc Gamma Receptor IIb,IgG Fc Receptor II-B,Fc-Gamma RII-B,FcRII-B,CDw32,FCG2,Low Affinity Immunoglobulin Gamma Fc Region Receptor II-B,Fc Fragment Of IgG, Low Affinity II, Receptor For (CD32),Fc Gamma RIIb,CD32 Antigen,CD32B,FCGR2,Fc-gamma-RIIb,FCGR2B,IGFR2,CD32,Fc Fragment Of IgG Receptor IIb,Fc-Gamma RII-C,Low Affinity Immunoglobulin Gamma Fc Region Receptor II-C,Fc Fragment Of IgG, Low Affinity IIb, Receptor For (CD32)
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

Product> Filter Results
Par statut du produit :
Par catégorie de produit :
Par espèce :
Par étiquette :
Par conjugaison :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
CDB-H5284 Human Human Fc gamma RIIB/C (CD32b/c) Protein, Strep Tag (MALS & SPR verified)
CDB-H5284-structure
CDB-H5284-sds
CDB-H5298 Human Human Fc gamma RIIB/C (CD32b/c) Protein, SUMO,His Tag (MALS & BLI verified)
CDB-H5298-structure
CDB-H5298-sds
CDB-H52S9 Human Human Fc gamma RIIB/C (CD32b/c) Protein, HSA,His Tag (MALS & BLI verified)
CDB-H52S9-structure
CDB-H52S9-sds
CDB-H82E0 Human Biotinylated Human Fc gamma RIIB/C (CD32b/c) Protein, Avitag™,His Tag (SPR & BLI & MALS verified)
CDB-H82E0-structure
CDB-H82E0-sds
CDB-H5228 Human Human Fc gamma RIIB/C (CD32b/c) Protein, His Tag (SPR & BLI & MALS verified)
CDB-H5228-structure
CDB-H5228-sds
ACRO Quality

Part of Bioactivity data

CDB-H5284-SPR
Fc gamma RIIB/C / CD32b/c SPR

Human CD32b/c Protein, Strep Tag (Cat. No. CDB-H5284) immobilized on CM5 Chip can bind Rituximab with an affinity constant of 10.2 μM as determined in a SPR assay (Biacore 8K) (QC tested).

Protocol
CDB-H5284-SPR
Fc gamma RIIB/C / CD32b/c SPR

Rituximab immobilized on CM5 Chip can bind Human CD32b/c Protein, Strep Tag (Cat. No. CDB-H5284) with an affinity constant of 5.18 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Protocol

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Obexelimab XmAb-5871; AMG-729 Phase 3 Clinical Xencor Inc Immunoglobulin G4-Related Disease; Lupus Erythematosus, Systemic Details
PRV-3279 HDM-3002; MGD-010; PRV-3279; CD32BxCD79B Phase 2 Clinical Macrogenics Inc Lupus Erythematosus, Systemic Details
BI-1206 6G-11; BI-1206 Phase 2 Clinical Bioinvent International Ab Lymphoma, B-Cell; Solid tumours; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia; Leukemia, Lymphocytic, Chronic, B-Cell Details
BI-1607 BI-1607 Phase 2 Clinical Bioinvent International Ab Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Breast Neoplasms; Metastatic breast cancer; Adenocarcinoma Details
NVG-2089 NVG-2089 Phase 1 Clinical Nuvig Therapeutics Inc Details
Obexelimab XmAb-5871; AMG-729 Phase 3 Clinical Xencor Inc Immunoglobulin G4-Related Disease; Lupus Erythematosus, Systemic Details
PRV-3279 HDM-3002; MGD-010; PRV-3279; CD32BxCD79B Phase 2 Clinical Macrogenics Inc Lupus Erythematosus, Systemic Details
BI-1206 6G-11; BI-1206 Phase 2 Clinical Bioinvent International Ab Lymphoma, B-Cell; Solid tumours; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia; Leukemia, Lymphocytic, Chronic, B-Cell Details
BI-1607 BI-1607 Phase 2 Clinical Bioinvent International Ab Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Breast Neoplasms; Metastatic breast cancer; Adenocarcinoma Details
NVG-2089 NVG-2089 Phase 1 Clinical Nuvig Therapeutics Inc Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
E-Mail
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Laisser un message

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap